ASCO Daily News

134 Episodes

1. What the FDA CAR T-Cell Therapy Investigation Means for Oncologists

   Published: 12/7/2023
2. Managing the Complexities of Oncology Practice in 2024

   Published: 12/7/2023
3. Solutions and Key Research to Advance High-Quality Cancer Care

   Published: 11/9/2023
4. How to Implement Universal Germline Testing for CRC

   Published: 11/2/2023
5. Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy

   Published: 10/12/2023
6. Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer

   Published: 9/28/2023
7. ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care

   Published: 8/17/2023
8. How Oncologists Are Confronting the Cancer Drug Shortage

   Published: 8/10/2023
9. AI Will Allow Doctors to Reclaim Time With Patients

   Published: 8/3/2023
10. Managing the Side Effects of Endocrine Therapy for Breast Cancer

    Published: 7/27/2023
11. The Emergence of Triplet Therapies in ccRCC in the Frontline Setting

    Published: 7/13/2023
12. Novel Therapies in GI Oncology at ASCO23

    Published: 6/28/2023
13. THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23

    Published: 6/27/2023
14. Spotlight on Immunotherapy at ASCO23

    Published: 6/26/2023
15. Highlights in Hematologic Malignancies at ASCO23

    Published: 6/23/2023
16. ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23

    Published: 6/22/2023
17. SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23

    Published: 6/21/2023
18. Addressing the Impact of Prior Authorization on Access to Cancer Treatment

    Published: 6/8/2023
19. ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy

    Published: 5/25/2023
20. ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies

    Published: 5/25/2023